v3.26.1
Business Segments - Adjusted EBITDA (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2024
Adjusted EBITDA      
Net sales $ 1,518,093 $ 1,296,215 $ 1,017,679
Cost of goods sold 1,005,578 896,273 704,587
Selling, general and administrative expenses 318,119 289,477 259,777
Add: Depreciation and amortization 51,514 45,605 36,178
Add: Acquisition-related cost of goods sold 1,956 5,679 521
Subtract: Insurance proceeds (3,563) (2,880) (899)
Adjusted EBITDA 333,309 253,643 169,717
Location, Statement of Income, Balance [Axis]: us-gaap:CostOfGoodsAndServicesSold      
Adjusted EBITDA      
Add: Phibro Forward income growth initiatives implementation costs   3,798  
Location, Statement of Income, Balance [Axis]: us-gaap:SellingGeneralAndAdministrativeExpense      
Adjusted EBITDA      
Add: Phibro Forward income growth initiatives implementation costs 8,646 6,978 366
Animal Health      
Adjusted EBITDA      
Net sales 1,162,219 962,796 706,482
Add: Acquisition-related cost of goods sold 1,956 5,679 521
Subtract: Insurance proceeds (954) (2,880) (899)
Adjusted EBITDA 303,578 222,260 145,606
Mineral Nutrition      
Adjusted EBITDA      
Net sales 282,341 253,240 243,663
Adjusted EBITDA 21,670 20,836 16,449
Performance Products      
Adjusted EBITDA      
Net sales 73,533 80,179 67,534
Adjusted EBITDA 8,061 10,547 7,662
Operating Segments      
Adjusted EBITDA      
Add: Depreciation and amortization 49,448 43,714 34,309
Operating Segments | Animal Health      
Adjusted EBITDA      
Cost of goods sold 692,528 607,069 428,683
Selling, general and administrative expenses 213,383 182,310 162,009
Add: Depreciation and amortization 46,268 40,475 30,194
Add: Phibro Forward income growth initiatives implementation costs   5,600  
Operating Segments | Animal Health | Location, Statement of Income, Balance [Axis]: us-gaap:CostOfGoodsAndServicesSold      
Adjusted EBITDA      
Add: Phibro Forward income growth initiatives implementation costs   3,798  
Operating Segments | Animal Health | Location, Statement of Income, Balance [Axis]: us-gaap:SellingGeneralAndAdministrativeExpense      
Adjusted EBITDA      
Add: Phibro Forward income growth initiatives implementation costs   1,771  
Operating Segments | Mineral Nutrition      
Adjusted EBITDA      
Cost of goods sold 255,664 226,864 222,363
Selling, general and administrative expenses 7,221 7,642 7,278
Add: Depreciation and amortization 2,214 2,102 2,427
Operating Segments | Performance Products      
Adjusted EBITDA      
Cost of goods sold 57,382 62,364 53,519
Selling, general and administrative expenses 9,056 8,405 8,041
Add: Depreciation and amortization $ 966 $ 1,137 $ 1,688